Cargando…
Tumor Mutation Burden-Associated LINC00638/miR-4732-3p/ULBP1 Axis Promotes Immune Escape via PD-L1 in Hepatocellular Carcinoma
Tumor mutation burden (TMB) is associated with immune infiltration, while its underlying mechanism in hepatocellular carcinoma (HCC) remains unclear. A long noncoding RNA (lncRNA)-related competitive endogenous RNA (ceRNA) network can regulate various tumor behaviors, and research about its correlat...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456090/ https://www.ncbi.nlm.nih.gov/pubmed/34568062 http://dx.doi.org/10.3389/fonc.2021.729340 |
_version_ | 1784570805878784000 |
---|---|
author | Qi, Feng Du, Xiaojing Zhao, Zhiying Zhang, Ding Huang, Mengli Bai, Yuezong Yang, Biwei Qin, Wenxing Xia, Jinglin |
author_facet | Qi, Feng Du, Xiaojing Zhao, Zhiying Zhang, Ding Huang, Mengli Bai, Yuezong Yang, Biwei Qin, Wenxing Xia, Jinglin |
author_sort | Qi, Feng |
collection | PubMed |
description | Tumor mutation burden (TMB) is associated with immune infiltration, while its underlying mechanism in hepatocellular carcinoma (HCC) remains unclear. A long noncoding RNA (lncRNA)-related competitive endogenous RNA (ceRNA) network can regulate various tumor behaviors, and research about its correlation with TMB and immune infiltration is warranted. Data were downloaded from TCGA and ArrayExpress databases. Cox analysis and machine learning algorithms were employed to establish a lncRNA-based prognostic model for HCC. We then developed a nomogram model to predict overall survival and odds of death for HCC patients. The association of this prognostic model with TMB and immune infiltration was also analyzed. In addition, a ceRNA network was constructed by using DIANA-LncBasev2 and the starBase database and verified by luciferase reporter and colocalization analysis. Multiplex immunofluorescence was applied to determine the correlation between ULBP1 and PD-L1. An eight-lncRNA (SLC25A30-AS1, HPN-AS1, LINC00607, USP2-AS1, HCG20, LINC00638, MKLN1-AS and LINC00652) prognostic score model was constructed for HCC, which was highly associated with TMB and immune infiltration. Next, we constructed a ceRNA network, LINC00638/miR-4732-3p/ULBP1, that may be responsible for NK cell infiltration in HCC with high TMB. However, patients with high ULBP1 possessed a poorer prognosis. Using multiplex immunofluorescence, we found a significant correlation between ULBP1 and PD-L1 in HCC, and patients with high ULBP1 and PD-L1 had the worst prognosis. In brief, the eight-lncRNA model is a reliable tool to predict the prognosis of HCC patients. The LINC00638/miR-4732-3p/ULBP1 axis may regulate immune escape via PD-L1 in HCC with high TMB. |
format | Online Article Text |
id | pubmed-8456090 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84560902021-09-23 Tumor Mutation Burden-Associated LINC00638/miR-4732-3p/ULBP1 Axis Promotes Immune Escape via PD-L1 in Hepatocellular Carcinoma Qi, Feng Du, Xiaojing Zhao, Zhiying Zhang, Ding Huang, Mengli Bai, Yuezong Yang, Biwei Qin, Wenxing Xia, Jinglin Front Oncol Oncology Tumor mutation burden (TMB) is associated with immune infiltration, while its underlying mechanism in hepatocellular carcinoma (HCC) remains unclear. A long noncoding RNA (lncRNA)-related competitive endogenous RNA (ceRNA) network can regulate various tumor behaviors, and research about its correlation with TMB and immune infiltration is warranted. Data were downloaded from TCGA and ArrayExpress databases. Cox analysis and machine learning algorithms were employed to establish a lncRNA-based prognostic model for HCC. We then developed a nomogram model to predict overall survival and odds of death for HCC patients. The association of this prognostic model with TMB and immune infiltration was also analyzed. In addition, a ceRNA network was constructed by using DIANA-LncBasev2 and the starBase database and verified by luciferase reporter and colocalization analysis. Multiplex immunofluorescence was applied to determine the correlation between ULBP1 and PD-L1. An eight-lncRNA (SLC25A30-AS1, HPN-AS1, LINC00607, USP2-AS1, HCG20, LINC00638, MKLN1-AS and LINC00652) prognostic score model was constructed for HCC, which was highly associated with TMB and immune infiltration. Next, we constructed a ceRNA network, LINC00638/miR-4732-3p/ULBP1, that may be responsible for NK cell infiltration in HCC with high TMB. However, patients with high ULBP1 possessed a poorer prognosis. Using multiplex immunofluorescence, we found a significant correlation between ULBP1 and PD-L1 in HCC, and patients with high ULBP1 and PD-L1 had the worst prognosis. In brief, the eight-lncRNA model is a reliable tool to predict the prognosis of HCC patients. The LINC00638/miR-4732-3p/ULBP1 axis may regulate immune escape via PD-L1 in HCC with high TMB. Frontiers Media S.A. 2021-09-08 /pmc/articles/PMC8456090/ /pubmed/34568062 http://dx.doi.org/10.3389/fonc.2021.729340 Text en Copyright © 2021 Qi, Du, Zhao, Zhang, Huang, Bai, Yang, Qin and Xia https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Qi, Feng Du, Xiaojing Zhao, Zhiying Zhang, Ding Huang, Mengli Bai, Yuezong Yang, Biwei Qin, Wenxing Xia, Jinglin Tumor Mutation Burden-Associated LINC00638/miR-4732-3p/ULBP1 Axis Promotes Immune Escape via PD-L1 in Hepatocellular Carcinoma |
title | Tumor Mutation Burden-Associated LINC00638/miR-4732-3p/ULBP1 Axis Promotes Immune Escape via PD-L1 in Hepatocellular Carcinoma |
title_full | Tumor Mutation Burden-Associated LINC00638/miR-4732-3p/ULBP1 Axis Promotes Immune Escape via PD-L1 in Hepatocellular Carcinoma |
title_fullStr | Tumor Mutation Burden-Associated LINC00638/miR-4732-3p/ULBP1 Axis Promotes Immune Escape via PD-L1 in Hepatocellular Carcinoma |
title_full_unstemmed | Tumor Mutation Burden-Associated LINC00638/miR-4732-3p/ULBP1 Axis Promotes Immune Escape via PD-L1 in Hepatocellular Carcinoma |
title_short | Tumor Mutation Burden-Associated LINC00638/miR-4732-3p/ULBP1 Axis Promotes Immune Escape via PD-L1 in Hepatocellular Carcinoma |
title_sort | tumor mutation burden-associated linc00638/mir-4732-3p/ulbp1 axis promotes immune escape via pd-l1 in hepatocellular carcinoma |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456090/ https://www.ncbi.nlm.nih.gov/pubmed/34568062 http://dx.doi.org/10.3389/fonc.2021.729340 |
work_keys_str_mv | AT qifeng tumormutationburdenassociatedlinc00638mir47323pulbp1axispromotesimmuneescapeviapdl1inhepatocellularcarcinoma AT duxiaojing tumormutationburdenassociatedlinc00638mir47323pulbp1axispromotesimmuneescapeviapdl1inhepatocellularcarcinoma AT zhaozhiying tumormutationburdenassociatedlinc00638mir47323pulbp1axispromotesimmuneescapeviapdl1inhepatocellularcarcinoma AT zhangding tumormutationburdenassociatedlinc00638mir47323pulbp1axispromotesimmuneescapeviapdl1inhepatocellularcarcinoma AT huangmengli tumormutationburdenassociatedlinc00638mir47323pulbp1axispromotesimmuneescapeviapdl1inhepatocellularcarcinoma AT baiyuezong tumormutationburdenassociatedlinc00638mir47323pulbp1axispromotesimmuneescapeviapdl1inhepatocellularcarcinoma AT yangbiwei tumormutationburdenassociatedlinc00638mir47323pulbp1axispromotesimmuneescapeviapdl1inhepatocellularcarcinoma AT qinwenxing tumormutationburdenassociatedlinc00638mir47323pulbp1axispromotesimmuneescapeviapdl1inhepatocellularcarcinoma AT xiajinglin tumormutationburdenassociatedlinc00638mir47323pulbp1axispromotesimmuneescapeviapdl1inhepatocellularcarcinoma |